Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma.
about
Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clustersProduction and Characterization of Monoclonal Antibodies Specific for a Conserved Epitope within Hepatitis C Virus Hypervariable Region 1Frequent Recovery and Broad Genotype 2 Diversity Characterize Hepatitis C Virus Infection in Ghana, West AfricaHepatitis C virus antigenic convergenceHuman recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries.Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.Hypervariable region diversity of hepatitis C virus and humoral response: comparison between patients with or without cirrhosis.Comparative analysis of amino acid sequences from envelope proteins isolated from different hepatitis C virus variants: possible role of conservative and variable regions.Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides.Mapping and characterization of B cell linear epitopes in the conservative regions of hepatitis C virus envelope glycoproteins.Genetic complexity and serum reactivity of HVR1 quasispecies of hepatitis C virus in patients with cirrhosis.Immunological evaluation of Escherichia coli-derived hepatitis C virus second envelope protein (E2) variants.Ratio of HCV structural antigens in protein-based vaccine formulations is critical for functional immune response induction.Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry
P2860
Q27469638-0170289D-AE6C-445C-8D44-C0FF22934450Q27470002-E56A1B49-B506-42BA-83FC-9269586A57ADQ27477557-4D8CA3AB-9399-4639-8696-44BB026EF55FQ28732097-BAF9069A-4015-4AA4-9976-5419D214D171Q30828468-B680CAC9-9F02-4AD5-BE42-7C05E62CE54DQ42994442-B0E7D3CB-99C0-49B7-88C6-08F4A1C5428DQ42994607-D8259A00-EF36-4545-BE35-8607ED1BC36AQ43000088-1C2E4F00-016B-438F-BF1F-8E81B93EE92DQ43035983-C50C1D73-347B-44F4-BA31-71DECBFE108EQ43037845-01312B23-C440-490F-876F-B356C23C46D2Q43038654-9E095703-992A-4396-BBEF-1DDFBFA1A048Q45735507-8D1FD312-DBC0-40F2-9970-721003B7872BQ50551505-536D479A-8D59-44D8-83C0-A2C4047678BBQ57490859-A2A59E7E-A571-4DCA-BE6E-B3F7FDCBD5CE
P2860
Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Reactivity of synthetic peptid ...... rus-seropositive human plasma.
@en
Reactivity of synthetic peptid ...... rus-seropositive human plasma.
@nl
type
label
Reactivity of synthetic peptid ...... rus-seropositive human plasma.
@en
Reactivity of synthetic peptid ...... rus-seropositive human plasma.
@nl
prefLabel
Reactivity of synthetic peptid ...... rus-seropositive human plasma.
@en
Reactivity of synthetic peptid ...... rus-seropositive human plasma.
@nl
P2093
P2860
P1476
Reactivity of synthetic peptid ...... rus-seropositive human plasma.
@en
P2093
P2860
P356
10.1002/(SICI)1096-9071(199701)51:1<67::AID-JMV11>3.0.CO;2-1
P577
1997-01-01T00:00:00Z